Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
148 hedge funds and large institutions have $558M invested in Momenta Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 54 reducing their positions, and 16 closing their positions.
408% more call options, than puts
Call options by funds: $3.89M | Put options by funds: $766K
38% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 16
11% more capital invested
Capital invested by funds: $502M → $558M (+$56.3M)
3% more funds holding
Funds holding: 143 → 148 (+5)
26% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
+$14.5M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$6.26M |
| 3 |
VAM
Visium Asset Management
New York
|
+$5.01M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$4.57M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$7.71M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.88M |
| 3 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
-$2.38M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.17M |
| 5 |
RIA
Regal Investment Advisors
Kentwood,
Michigan
|
-$2.09M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
T
151
Tahithromos
New York
| – | -$776K | -68,456 | Closed |
|
152
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$567K | -50,000 | Closed |
|
|
CCMH
153
Cornerstone Capital Management Holdings
New York
| – | -$183K | -16,099 | Closed |
|
154
Jane Street
New York
| – | -$155K | -13,701 | Closed |
|
|
AL
155
Airain Ltd
St. Peter Port,
Guernsey
| – | -$128K | -11,325 | Closed |
|
|
CSS
156
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$117K | -10,300 | Closed |
|
|
BJ
157
BlackRock Japan
Tokyo,
Japan
| – | -$76K | -6,692 | Closed |
|
|
PCM
158
Prelude Capital Management
New York
| – | -$49K | -4,300 | Closed |
|
159
Group One Trading
Chicago,
Illinois
| – | -$36.5K | -3,191 | Closed |
|
160
BNP Paribas Financial Markets
Paris,
France
| – | -$32.4K | -2,856 | Closed |
|
161
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$10K | -879 | Closed |
|
|
ST
162
Spot Trading
Chicago,
Illinois
| – | -$2K | -192 | Closed |
|
163
SEI Investments
Oaks,
Pennsylvania
| – | +$80 | +7 | New |
|
|
IC
164
Intersect Capital
San Ramon,
California
| – | +$114 | +10 | New |
|
MNTA Hedge Fund Activity: Q4 2014 in Review
148 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2014, worth a combined $558M — up 11% from $502M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new MNTA positions and 16 closed out — a net gain of 6 holders — while 40 added to existing stakes and 54 trimmed.
The largest buyer was Tocqueville Asset Management, adding an estimated $14.5M. The largest seller was Sectoral Asset Management, cutting an estimated $7.71M.
- 148 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2014, up from 143 in Q3 2014.
- Funds reported $558M of Momenta Pharmaceuticals, Inc. stock for Q4 2014, up 11% quarter-over-quarter.
- 22 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2014 and 16 closed out, a net change of +6 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q4 2014 was Tocqueville Asset Management, an estimated $14.5M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q4 2014 was Sectoral Asset Management, an estimated $7.71M sold.
Based on aggregated 13F filings for Q4 2014.